Castle Biosciences (CSTL) Return on Capital Employed (2019 - 2026)
Castle Biosciences (CSTL) posted Return on Capital Employed of 6.45% for Q2 2026, little changed sequentially from 6.47% in Q1 2026, and down 157.0% YoY from 11.31% in Q2 2025.
Castle Biosciences (CSTL) Return on Capital Employed (2019 - 2026) Analysis & Trends
Castle Biosciences has reported Return on Capital Employed for 8 years, with the latest figure at 6.45% in Q2 2026.
- Quarterly Return on Capital Employed fell 157.0% year-over-year to 6.45% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 6.45% (down 157.0% YoY) and the FY2025 annual result came in at 8.8%, down 1076.0% from the prior year.
- Return on Capital Employed held at 6.45% in Q2 2026 per CSTL's latest filing, from 6.47% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 1.83% in Q4 2024 and troughed at 24.73% in Q2 2023.
- A 5-year average of 10.65% and a median of 9.21% in 2024 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2022 and 2024: Return on Capital Employed sank 1175 bps in 2022, then jumped 2136 bps in 2024.
- Over 5 years, Return on Capital Employed stood at 17.49% in 2022, then increased by 2 bps to 17.12% in 2023, then jumped by 111 bps to 1.83% in 2024, then sank by 566 bps to 8.53% in 2025, then increased by 24 bps to 6.45% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 6.45%, 6.47%, and 8.53% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 8.30% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 6.42% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -13.91% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 14.57% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 10.49% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 68.60% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 17.55% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 49.80% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 8.97% |
| 10 | Castle Biosciences | 1.04 Bn | 773.13 Mn | 79.85 Mn | -6.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.45% |
| Mar 31, 2026 | -6.47% |
| Dec 31, 2025 | -8.53% |
| Sep 30, 2025 | -7.01% |
| Jun 30, 2025 | -4.88% |
| Mar 31, 2025 | -2.88% |
| Dec 31, 2024 | 1.83% |
| Sep 30, 2024 | -0.23% |
| Jun 30, 2024 | -3.64% |
| Mar 31, 2024 | -9.89% |
| Dec 31, 2023 | -17.12% |
| Sep 30, 2023 | -21.59% |
| Jun 30, 2023 | -24.73% |
| Mar 31, 2023 | -19.62% |
| Dec 31, 2022 | -17.49% |
| Sep 30, 2022 | -15.30% |
| Jun 30, 2022 | -13.09% |
| Mar 31, 2022 | -14.57% |
| Dec 31, 2021 | -9.47% |
| Sep 30, 2021 | -6.76% |